UBS analyst Karl Keirstead maintains Oracle (NYSE:ORCL) with a Buy and raises the price target from $175 to $200.
UBS Maintains Buy on Oracle, Raises Price Target to $200
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.